Vanguard Group’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.8M | Sell |
|
|||||
|
2025
Q1 | $8.66M | Buy |
|
|||||
|
2024
Q4 | $8.67M | Buy |
|
|||||
|
2024
Q3 | $22.8M | Sell |
|
|||||
|
2024
Q2 | $37.5M | Sell |
|
|||||
|
2024
Q1 | $63.5M | Buy |
|
|||||
|
2023
Q4 | $85.7M | Sell |
|
|||||
|
2023
Q3 | $66.6M | Buy |
|
|||||
|
2023
Q2 | $67.2M | Buy |
|
|||||
|
2023
Q1 | $52.2M | Buy |
|
|||||
|
2022
Q4 | $61M | Buy |
|
|||||
|
2022
Q3 | $82.3M | Buy |
|
|||||
|
2022
Q2 | $78.5M | Sell |
|
|||||
|
2022
Q1 | $131M | Buy |
|
|||||
|
2021
Q4 | $177M | Buy |
|
|||||
|
2021
Q3 | $265M | Sell |
|
|||||
|
2021
Q2 | $367M | Buy |
|
|||||
|
2021
Q1 | $267M | Buy |
|
|||||
|
2020
Q4 | $408M | Buy |
|
|||||
|
2020
Q3 | $160M | Sell |
|
|||||
|
2020
Q2 | $170M | Buy |
|
|||||
|
2020
Q1 | $93.4M | Buy |
|
|||||
|
2019
Q4 | $135M | Buy |
|
|||||
|
2019
Q3 | $98.2M | Buy |
|
|||||
|
2019
Q2 | $106M | Buy |
|
|||||
|
2019
Q1 | $96.2M | Buy |
|
|||||
|
2018
Q4 | $87.9M | Buy |
|
|||||
|
2018
Q3 | $119M | Buy |
|
|||||
|
2018
Q2 | $129M | Buy |
|
|||||
|
2018
Q1 | $100M | Buy |
|
|||||
|
2017
Q4 | $85.1M | Buy |
|
|||||
|
2017
Q3 | $55.1M | Buy |
|
|||||
|
2017
Q2 | $36.5M | Buy |
|
|||||
|
2017
Q1 | $43.2M | Buy |
|
|||||
|
2016
Q4 | $21.4M | Buy |
|
|||||
|
2016
Q3 | $16.8M | Buy |
|
|||||
|
2016
Q2 | $13M | Sell |
|
|||||
|
2016
Q1 | $25.9M | Buy |
|